Mark Awad, MD, PHD
NPI 1831359355 · Medical Oncology Physician · New York, NY
Enrolled with Medicare as Practitioner - Medical Oncology · source: CMS PECOS Public Provider Enrollment (2026.04.01)
Mark Awad, MD, PHD is a Medical Oncology Physician provider in New York, NY (NPI 1831359355).
Provider details
- NPI number
- 1831359355
- Entity type
- Individual
- Primary specialty
- Medical Oncology PhysicianAllopathic & Osteopathic Physicians
- Credential
- MD, PHD
- Sex
- Male
- Sole proprietor
- No
- License
- 333119 (NY)
Specialties & taxonomies
Allopathic & Osteopathic Physicians
Profile Score
A profile completeness & documented-activity index — NOT a quality, outcomes, or patient-satisfaction rating.
- Registry tenure25% of score
18 yrs in NPPES registry
- Profile completeness25% of score
100% of core fields populated
- Practice footprint15% of score
1 documented practice location
- Medicare service volume (vs. specialty peers)25% of score
219 Medicare services, 2024 (ranked within specialty)
- Open Payments transparency10% of score
Has Open Payments disclosures (2024)
Medicare volume is ranked against active providers in the same specialty. Signals a provider has no public data for (e.g. Medicare claims) are left out of the score entirely — never counted as zero — so providers without that data are not penalized. See the full formula and weights in our .
What this provider does (Medicare)
Based on Medicare fee-for-service claims, 2024; not all care is captured.
| Service (HCPCS) | Medicare services | Typical Medicare-allowed (2024) |
|---|---|---|
| Established Patient Office Or Other Outpatient Visit With Moderate Level of Decision Making, If Using Time, 30 Minutes Or More99214 | 57 | $108 |
| Established Patient Office Or Other Outpatient Visit With High Level of Medical Decision Making, If Using Time, 40 Minutes Or More99215 | 54 | $157 |
| Subsequent Hospital Care With Moderate Levelof Medical Decision Making, If Using Time, at Least 35 Minutes99232 | 48 | $82 |
| Established Patient Office Or Other Outpatient Visit With High Level of Medical Decision Making, If Using Time, 40 Minutes Or More99215 | 25 | $151 |
| Established Patient Office Or Other Outpatient Visit With Moderate Level of Decision Making, If Using Time, 30 Minutes Or More99214 | 19 | $102 |
| New Patient Office Or Other Outpatient Visit With a High Level of Medical Decision Making, If Using Time, 60 Minutes Or More |
What this provider prescribes (Medicare Part D)
Top drugs by Medicare Part D claim volume, 2024 · 5 distinct drugs on file.
| Drug | Part D claims (2024) | Beneficiaries |
|---|---|---|
| Apixabanbrand: Eliquis | 19 | — |
| Dexamethasone | 19 | 12 |
| Osimertinib Mesylatebrand: Tagrisso | 18 | — |
| Alectinib Hclbrand: Alecensa | 13 | — |
| Ondansetronbrand: Ondansetron Odt | 13 | — |
Medicare Part D only. These counts cover prescriptions paid through Medicare Part D in 2024 — they do notinclude cash-pay, commercial-insurance, Medicaid, or Part B–administered drugs, and badly undercount high cash-pay categories (e.g. GLP-1 weight-loss, testosterone, and ED medications). Any drug with 10 or fewer claims is omitted by CMS, and beneficiary counts under 11 are suppressed — so a missing drug means no Part D record, never zero. This is a factual claims summary, not an endorsement, not medical advice, and not a consumer report. Source: CMS Medicare Part D Prescribers — by Provider and Drug.
Transparency — industry payments
Based on CMS Open Payments, 2024; not all care is captured.
$38,748 across 33 records (Open Payments 2024)
Open Payments discloses payments and transfers of value (meals, travel, consulting, research, royalties) from drug and device makers to providers. This is a transparency signal, not a verdict — such payments are legal and common, and their presence is neither an endorsement nor a criticism. Source: CMS Open Payments, program year 2024.
Practice location
Mailing address
Registry dates
- Enumerated
- 2008-06-10
- Last updated
- 2024-10-09
- Certified
- 2024-10-09
Frequently asked questions
- What is Mark Awad's NPI number?
- Mark Awad's National Provider Identifier (NPI) is 1831359355, a unique 10-digit ID issued by CMS for use in standard healthcare transactions.
- What is Mark Awad's specialty?
- Mark Awad is listed in the NPPES registry with a primary specialty of Medical Oncology Physician (Allopathic & Osteopathic Physicians).
- Where is Mark Awad located?
- Mark Awad's practice location on file with NPPES is 530 E 74th St, New York, NY 10021-3459.
- What is Mark Awad's phone number?
- The practice phone number listed in the NPPES registry for Mark Awad is (212) 639-2000.
- Does Mark Awad accept Medicare?
- Mark Awad is approved to bill Medicare according to CMS PECOS enrollment data (2026.04.01). Confirm current participation with the provider before scheduling.
- Is Mark Awad's NPI active?
- Yes — Mark Awad's NPI (1831359355) is active in the NPPES registry as of the last update on 2024-10-09.
Source: CMS NPPES Data Dissemination (June 2026). NPI Central is not affiliated with CMS. Data is provided as-is from the public registry.